McMullian Ryals

CEO McMullian Ryals sells 209,000 shares (20.4% of holdings) at $8.03; stock now -57.1% from 52-week high, -23.6% in 90 days

McMullian Ryals sold 209,000 shares at $8.03 on 2026-04-01, reducing his FLO holdings from 1.02M to 813.4K shares. The transaction occurs as the stock trades at $8.24, down 57.1% from its 52-week high of $19.21 and down 23.6% over the past 90 days. His prior two open-market sells across all tickers showed a 100% well-timed rate at the 90-day mark (average 90-day return -19.7%), and at FLO specifically, his last two sales in January and September 2025 were followed by declines of 24.2% and 15.2% respectively. The current sale occurs at price levels approaching the 52-week low of $8.13, consistent with his established pattern of sells preceding downward price movement. Investors should track whether this sale precedes further deterioration given the weak fundamentals (P/E of 58.86, modest 3.0% annual revenue growth) and the stock's extended decline from peak valuations.

CEO McMullian Ryals sold 209,000 shares (209.0K shares) of FLO at $10.87 on 2026-01-02 for $2.3M, reducing holdings by 13.5%.

McMullian Ryals (Chairman and CEO) executed a substantial open-market sale of 209,000 shares (209.0K shares) at $10.87, representing a 13.5% reduction in his holdings from 1,542,988 to 1,333,988 shares. The sale occurred as the stock trades at $10.79, down 48.1% from its 52-week high of $20.78 and off 14.4% over 90 days, while annual revenue growth stands at +0.2% and the company trades at a P/E of 11.73. Ryals's prior two trades at Flowers Foods (a September 2025 sell and a December 2023 buy) both demonstrated favorable 90-day timing outcomes, with the September sell showing a -15.2% subsequent return—a pattern consistent with his cross-ticker track record showing a 100% well-timed sell rate. The concentration and scale of this sale warrant monitoring given the stock's extended decline from recent highs.

CEO McMullian Ryals sells 350,000 FLO shares at $12.82; stock now down 45.3% from 52-week high and -15.4% in 30 days.

McMullian Ryals, Chairman and CEO, sold 350,000 shares (22.1% of pre-transaction holdings) at $12.82 on 2025-09-25, reducing his stake from 1,581,380 to 1,231,380 shares for $4,488,750.00 total. The sale occurred in a deteriorating price environment: the stock is now -45.3% from its 52-week high of $23.32, -15.4% over 30 days, and -20.1% over 90 days. His single prior trade at this ticker (a buy on 2023-12-18) delivered a +3.2% 90-day return, but that historical success does not apply to current market conditions where the security has sustained significant losses. With fundamentals showing only +0.2% annual revenue growth and a P/E of 12.27, the timing of this large equity reduction in a weakening stock warrants investor attention to assess whether further deterioration is anticipated.